QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials 期刊论文 DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 卷号: 143, 页码: 34-42 作者:  Wang, Qian;  Liu, Lu;  Gao, Ling;  Li, Qiu 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Diabetes Millitus  Meta-analysis  Glucagon-like peptide-1 receptors  Cardiovascular outcomes   Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review 期刊论文 CLINICAL DRUG INVESTIGATION, 2016, 卷号: 36, 期号: 6, 页码: 433-441 作者:  Guo, Xia;  Yang, Qing;  Dong, Jianjun;  Liao, Lin;  Zhang, Weiwei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/16 Glucagon-like peptide 1 receptor agonist therapy is more efficacious than insulin glargine for poorly controlled type 2 diabetes: A systematic review and meta-analysis 期刊论文 Journal of diabetes, 2015, 卷号: 7, 期号: 3, 页码: 322-328 作者:  Liu, Fu-peng;  Dong, Jian-jun;  Yang, Qing;  Xue, Xian-zhong;  Ren, Zhong-fa 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/17 diabetes mellitus  GLP-1 receptor agonist  hyperlipidemia  insulin glargine   Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease 期刊论文 JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2015, 卷号: 35, 期号: 3, 页码: 333-336 作者:  Li, Chao-lin;  Zhao, Lu-jie;  Zhou, Xin-li;  Wu, Hui-xiao;  Zhao, Jia-jun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/17 glucagon-like peptide-1 receptor agonists  dipeptidyl peptidase-4  non-alcoholic fatty liver disease  insulin resistance  type 2 diabetes  mellitus   Review on the Effect of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Non-Alcoholic Fatty Liver Disease 期刊论文 Journal of Huazhong University of Science and Technology(Medical Sciences), 2015, 期号: 03, 页码: 333-336 作者:  Li CL(李超林);  Zhao LJ(赵璐杰);  Zhou XL(周新丽);  Wu HX(吴慧潇);  Zhao JJ(赵家军) 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/17 glucagon-like peptide-1 receptor agonists  dipeptidyl peptidase-4  non-alcoholic fatty liver disease  insulin resistance  type 2 diabetes mellitus   Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway 期刊论文 MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 卷号: 339, 期号: 1-2, 页码: 25-33 作者:  Liu, Fu-qiang;  Zhang, Xiang-li;  Gong, Lei;  Wang, Xu-ping;  Wang, Juan 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/23 Glucagon-like peptide-1 (GLP-1)  Islet microvascular endothelial cells  Oxidized low-density lipoprotein  PARP-1  iNOS  GLP-1 receptor